These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14559371)

  • 21. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 22. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
    Chlebowski RT; Prentice RL
    J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone replacement and breast cancer. A remaining controversy?
    Adami HO; Persson I
    JAMA; 1995 Jul; 274(2):178-9. PubMed ID: 7596008
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.
    Newcomb PA; Longnecker MP; Storer BE; Mittendorf R; Baron J; Clapp RW; Bogdan G; Willett WC
    Am J Epidemiol; 1995 Oct; 142(8):788-95. PubMed ID: 7572954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer: the role of hormone therapy.
    Creasman WT
    Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of oestrogens and progestin and the risk of breast cancer in post-menopausal women. G.A. Colditz et al. N. Engl. J. Med. 1995; 332: 1589-93.
    Kauppila A
    Pharmacol Res; 1995 Dec; 32(6):327. PubMed ID: 8736481
    [No Abstract]   [Full Text] [Related]  

  • 27. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 28. Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.
    Colditz GA
    Breast Cancer Res; 2007; 9(4):108. PubMed ID: 17666116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
    Colditz GA
    J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
    Shapiro S
    Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk of breast cancer with HRT depends on therapy type and duration.
    Saul H; Gursul D; Cassidy S; Vinogradova Y
    BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
    Lyytinen H; Ylikorkala O
    Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent studies bring risks, benefits of hormone replacement therapy under scrutiny.
    Friedrich MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1287-8. PubMed ID: 11535698
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy and breast cancer.
    Maguire PJ
    J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.